Research map: Rebastinib inhibits cerebral cavernous malformation in a chronic mouse model

Back to the article

Papers in this map

  1. Incidental Findings on Brain MRI in the General Population · Meike Willemijn Vernooij · 2007 · 1634 citations · Cited by this paper
  2. Characteristics Three waves of pyripyropene fungal alkaloids and synthetic derivatives targeting ACAT2 as insecticides, anti-atherosclerosis and anticancer agents. · 2026 · Related
  3. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research* · Nathalie Percie du Sert · 2020 · 1459 citations · Cited by this paper
  4. Low-molecular-weight fucoidan inhibits HMGB1-induced thromboinflammation by modulating HMGB1-TLR4 axis · 2026 · Related
  5. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas · Sophie Laberge · 1999 · 488 citations · Cited by this paper
  6. Poly(I:C) and QS-21 combination suppresses breast tumor growth and metastasis by repolarizing tumor associated macrophages to anti-tumor macrophages · 2026 · Related
  7. Mutations within the Programmed Cell Death 10 Gene Cause Cerebral Cavernous Malformations · Françoise Bergametti · 2004 · 454 citations · Cited by this paper
  8. PGC-1α mediates ER stress–driven apoptotic signaling during gemfibrozil treatment in glioblastoma · 2026 · Related
  9. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases · Kevin J. Whitehead · 2009 · 381 citations · Cited by this paper
  10. CTSB-Associated Inflammation and Macrophage Interaction in Heart Failure Following Myocardial Infarction and Potential Therapeutic Implications of Quercetin · 2026 · Related
  11. Discovery of 3-[2-(Imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a Potent, Orally Active Pan-Inhibitor of Breakpoint Cluster Region-Abelson (BCR-ABL) Kinase Including the T315I Gatekeeper Mutant · Wei‐Sheng Huang · 2010 · 370 citations · Cited by this paper
  12. S14G-humanin (HNG) ameliorates diabetic nephropathy tubular injury by inhibiting Z-DNA/ZBP1-mediated necroptosis · 2026 · Related
  13. Mutations in a Gene Encoding a Novel Protein Containing a Phosphotyrosine-Binding Domain Cause Type 2 Cerebral Cavernous Malformations · Christina L. Liquori · 2003 · 348 citations · Cited by this paper
  14. Induction and Propagation of Ferroptosis Evasion by FTH1P7 Drives Sorafenib Resistance in Hepatocellular Carcinoma · 2026 · Related
  15. Cerebral cavernous malformations arise from endothelial gain of MEKK3–KLF2/4 signalling · Zinan Zhou · 2016 · 336 citations · Cited by this paper
  16. A functional coupling of TRPA1 and TMEM16A channels regulates endothelium-dependent hyperpolarization-mediated vasorelaxation of mesenteric resistance arteries in healthy and septic mice · 2026 · Related
  17. ADP-Glo: A Bioluminescent and Homogeneous ADP Monitoring Assay for Kinases · Hicham Zegzouti · 2009 · 286 citations · Cited by this paper
  18. Role of Abca7-related microglial responses in linking type 2 diabetes mellitus to Alzheimer's disease progression: Evidence from single-cell transcriptomic analysis and experimental validation in animal and cell models · 2026 · Related
  19. Mutations within the MGC4607 Gene Cause Cerebral Cavernous Malformations · Christian Denier · 2004 · 242 citations · Cited by this paper
  20. TIE2 links MEKK3–KLF2/4 and PI3K signaling in cerebral cavernous malformation · 2026 · Related
  21. The Cerebral Cavernous Malformation Pathway Controls Cardiac Development via Regulation of Endocardial MEKK3 Signaling and KLF Expression · Zinan Zhou · 2015 · 177 citations · Cited by this paper
  22. Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1 · Malek Najjar · 2015 · 148 citations · Cited by this paper
  23. Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice · Aubrey C. Chan · 2011 · 146 citations · Cited by this paper
  24. Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults · Kelly D. Flemming · 2017 · 139 citations · Cited by this paper
  25. Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation · Jiancong Weng · 2021 · 108 citations · Cited by this paper
  26. Chronic Myeloid Leukemia · Elias Joseph Jabbour · 2025 · 98 citations · Cited by this paper
  27. CCM3 Mutations Are Associated with Early-Onset Cerebral Hemorrhage and Multiple Meningiomas · Florence Riant · 2013 · 93 citations · Cited by this paper
  28. Binding Kinetics Survey of the Drugged Kinome · Victoria Georgi · 2018 · 91 citations · Cited by this paper
  29. Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations · Jian Tu · 2005 · 87 citations · Cited by this paper
  30. PDCD10 Gene Mutations in Multiple Cerebral Cavernous Malformations · Maria Sole Cigoli · 2014 · 65 citations · Cited by this paper
  31. Genetic Targeting of Organ-Specific Blood Vessels · Wenjuan Pu · 2018 · 64 citations · Cited by this paper
  32. The CCM1–CCM2 complex controls complementary functions of ROCK1 and ROCK2 that are required for endothelial integrity · Justyna Lisowska · 2018 · 62 citations · Cited by this paper
  33. Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations · Jaesung Peter Choi · 2018 · 57 citations · Cited by this paper
  34. Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia · Jörge E. Cortes · 2016 · 53 citations · Cited by this paper
  35. Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model · Huanjiao Jenny Zhou · 2021 · 53 citations · Cited by this paper
  36. Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican · Courtney C. Hong · 2020 · 52 citations · Cited by this paper
  37. Ponatinib in the therapy of chronic myeloid leukemia · Marc Poch Martell · 2016 · 39 citations · Cited by this paper
  38. Cavernous Malformations of the Central Nervous System · Edward R. Smith · 2024 · 38 citations · Cited by this paper
  39. Role of pericytes in the development of cerebral cavernous malformations · Zifeng Dai · 2022 · 25 citations · Cited by this paper

Source: OpenAlex (CC0)